Successful use of metronomic vinblastine and fluorothymidine pet imaging for the management of intramedullary spinal cord anaplastic oligoastrocytoma in a child

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

DEMLOVÁ Regina MELICHÁRKOVÁ Kristýna ŘEHÁK Zdeněk KŘEN Leoš OŠLEJŠKOVÁ Hana ŠTĚRBA Jaroslav

Year of publication 2014
Type Article in Periodical
Magazine / Source Current Oncology
MU Faculty or unit

Faculty of Medicine

Citation
Doi http://dx.doi.org/10.3747/co.21.2147
Field Oncology and hematology
Keywords Biomarkers; Metronomic chemotherapy; Pediatric glioma; PET imaging; Vinblastine
Description Background: Children with high-grade glioma still have a poor prognosis despite the use of multimodal therapy including surgery, radiotherapy, and chemotherapy. New therapeutic strategies and methods evaluating such therapies are needed. Observation: Here we describe a child with anaplastic oligodendroglioma of the spinal cord who was unable to tolerate standard chemoradiotherapy and who had still-vital residual tumour during therapy. A good response was obtained with low-dose metronomic treatment containing vinblastine. The treatment was guided according to gradual response assessed using various positron-emission tomography tracers. Conclusions: Metronomic treatment guided by positron-emission tomography could be a reasonable option in some high-risk pediatric tumours.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.